NCT04354545View on ClinicalTrials.gov

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

UnknownOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
GlaucomaOcular Surface Disease
Interventions
DRUG

Xiidra (Lifitegrast ophthalmic solution) 5%

FDA approved lifitegrast opthalmic solution eye drop

Trial Locations (1)

92708

RECRUITING

Doheny Eye Center UCLA, Fountain Valley

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT04354545 - Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications | Biotech Hunter | Biotech Hunter